rxstat › Shortages › Oxybutynin Chloride

Oxybutynin Chloride shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Oxybutynin Chloride products are in shortage in Canada (2 of 11 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
2 / 11
In shortage since
Mar 10, 2017
Reports on file
36
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-OXYBUTYNIN
5MG · TABLET · APOTEX INC
DIN 02163543 · since Oct 8, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-OXYBUTYNIN
5MG · TABLET · APOTEX INC
DIN 02163543 · since Mar 4, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-OXYBUTYNIN
1MG · SYRUP · APOTEX INC
DIN 02231089 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Discontinued
OXYBUTYNIN
5MG · TABLET · SANIS HEALTH INC
DIN 02350238
Discontinued
OXYBUTYNIN
5MG · TABLET · SANIS HEALTH INC
DIN 02350238
Resolved
OXYBUTYNIN
5MG · TABLET · SANIS HEALTH INC
DIN 02350238 · ended Aug 11, 2025 · Disruption of the manufacture of the drug.
Resolved
OXYBUTYNIN
5MG · TABLET · SANIS HEALTH INC
DIN 02350238 · ended Aug 11, 2024 · Disruption of the manufacture of the drug.
Resolved
PMS-OXYBUTYNIN
5MG · SYRUP · PHARMASCIENCE INC
DIN 02223376 · ended Mar 23, 2025 · Disruption of the manufacture of the drug.
Discontinued
TEVA-OXYBUTYNIN
5MG · TABLET · TEVA CANADA LIMITED
DIN 02230394
Discontinued
TEVA-OXYBUTYNIN
5MG · TABLET · TEVA CANADA LIMITED
DIN 02230394
Resolved
PMS-OXYBUTYNIN
5MG · SYRUP · PHARMASCIENCE INC
DIN 02223376 · ended Sep 29, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-OXYBUTYNIN
5MG · TABLET · APOTEX INC
DIN 02163543 · ended Jul 12, 2023 · Disruption of the manufacture of the drug.

Showing 12 of 36 reports. All reports are on file with Health Canada.

What's happening

Oxybutynin Chloride is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Oxybutynin Chloride is classified under “OTHER UROLOGICALS, INCL ANTISPASMODICS” (ATC G04BD).

Recent changes

Common questions

When will Oxybutynin Chloride be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Oxybutynin Chloride in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (other urologicals, incl antispasmodics)

Widespread shortageAlprostadil3 of 5 reported products affectedWidespread shortageFlavoxate2 of 2 reported products affectedWidespread shortageMirabegron2 of 2 reported products affected · est. return Jul 3, 2026Widespread shortageTolterodine8 of 16 reported products affected · est. return Sep 8, 2026Partial shortageDarifenacin1 of 6 reported products affected · est. return Jul 10, 2026Partial shortageFesoterodine1 of 4 reported products affected · est. return Jan 29, 2027

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.